BSE filing, BSE: 543207. Summary written from the filing by ALFA Finder's alert engine.
Natural Biocon (India) Ltd: key numbers
- Share price
- ₹1.71
- Market cap
- ₹4.41 Cr
- Revenue (annual)
- ₹2.54 Cr
- Net profit (annual)
- ₹-0.04 Cr
- P/E (TTM)
- -23.2×Sector 34.1×
- Promoter holding
- 9.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natural Biocon (India) Ltd
All →Natural Biocon (India) Other Announcement
Natural Biocon (India) Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Natural Biocon (India) Management Change
Ms. Shruti Sharma has resigned as Company Secretary and Compliance Officer of Natural Biocon (India) Ltd, effective from 26th September 2026.
Natural Biocon (India) Board Meeting Outcome
Natural Biocon approved the Director's report and scheduled its 34th Annual General Meeting for September 30, 2026. It also announced leadership changes, including new director appointments.
Natural Biocon (India) Board Meeting Date
Natural Biocon (India) Ltd will hold a board meeting on September 5, 2026, to consider AGM matters and approve various annual reports.
Natural Biocon (India) Q1 FY27 Results: Net Profit ₹0 Cr
Natural Biocon (India) Ltd reported net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Natural Biocon (India) Board Meeting Date
Natural Biocon (India) Ltd will hold a board meeting on August 14, 2026. The agenda includes approving quarterly results and appointing new statutory auditors.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.